13,600.00
+220(+1.64%)
Currency In KRW
Address
21 Biopolis Road
Singapore, 138567
Singapore
Phone
65 6924 6535
Sector
Healthcare
Industry
Biotechnology
Employees
54
First IPO Date
February 09, 2021
| Name | Title | Pay | Year Born |
| Ms. So-Yeon Park | Chairman & Chief Executive Officer | 0 | 1963 |
| Mr. Jinwoo Kim | Chief Financial Officer & Director | 0 | 1964 |
| Michael Ruppert | Head of Business Development | 0 | 1967 |
| Ms. Kay K.H. Lee | Clinical Development Manager | 0 | 1970 |
| Mr. Ghislain M.C Bonamy | General Manager of Licensing | 0 | 1979 |
| Ms. Chung Shii Hii | Chief Technology Officer | 0 | 1979 |
| Wei Hsiung Lee | Secretary | 0 | 1979 |
| Dong -Jo Shin | Head of Finance | 0 | 1973 |
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.